American Stock Exchange Lists Common Stock of Medicure Inc. NEW YORK, Feb. 17 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today listed the common stock of Medicure Inc. under the ticker symbol MCU. Medicure Inc. is a cardiovascular drug discovery and development Company focused on developing effective therapeutics for unmet needs in the field of cardiovascular medicine. The Company's lead drug, MC-1, is focused on the prevention and treatment of ischemia, ischemic reperfusion injury,and stroke. The cardiovascular and stroke market is the largest pharmaceutical sector with annual global sales of over US $70 billion. "We are pleased to welcome Medicure to the American Stock Exchange," said John McGonegal, senior vice president of the Amex Equities Group. "We look forward to working with Medicure in building increased investor awareness and visibility within the investment community." The specialist in Medicure Inc. will be Kellogg Capital Group. For further information on MCU and other Amex-listed companies, please visit http://www.amex.com/ . The American Stock Exchange(R) (Amex(R)) is the only primary exchange that offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 138 ETFs.The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit http://www.amex.com/ . DATASOURCE: The American Stock Exchange CONTACT: Lynn Teresky of American Stock Exchange, +1-212-306-1654, Web site: http://www.amex.com/

Copyright